Miguel C. Riella

Curitiba PR, 
Curitiba, PR, BR 
Curitiba PR, 
Curitiba, PR, BR 

Overview

Miguel Riella practices practicing medicine in Curitiba, Brazil.

His clinical expertise encompasses Chronic Kidney Disease, Milk-Alkali Syndrome, Hypercalcemia, Kidney Transplant, and Angioplasty.

He is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Curitiba PR, Curitiba, PR, Brazil
Other Locations
2689 Iguassu Avenue, Curitiba, PR 80240030, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Evaluation of Clinical Efficacy and Immunogenicity of Drug Eritromax® at Blau Farmacêutica S.A. Compared to Eprex®, Produced by Janssen-Cilag Laboratory in Participants With Secondary Anemia to Chronic Kidney Disease.
Evaluation of Clinical Efficacy and Immunogenicity of Drug Eritromax® at Blau Farmacêutica S.A. Compared to Eprex®, Produced by Janssen-Cilag Laboratory in Participants With Secondary Anemia to Chronic Kidney Disease.
Enrollment Status: Terminated
Publish Date: August 20, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

74 Total Publications

A randomized controlled trial of cutting balloons versus conventional angioplasty in arteriovenous fistula stenosis.
A randomized controlled trial of cutting balloons versus conventional angioplasty in arteriovenous fistula stenosis.
Journal: The journal of vascular access
Published: November 03, 2025

Frequently Asked Questions about Miguel C. Riella

Is Miguel C. Riella a top-rated expert for Chronic Kidney Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Miguel C. Riella is classified as an Experienced expert for Chronic Kidney Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Miguel C. Riella participate in research or clinical trials?

Yes. Miguel C. Riella has published 74 articles and abstracts on conditions like Chronic Kidney Disease. You can view a list of Miguel C. Riella's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Riella's expertise for a condition
ConditionClose
        View All 14 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile